The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA

Chem Biol. 2005 Dec;12(12):1317-24. doi: 10.1016/j.chembiol.2005.09.014.

Abstract

Mana-Hox, an analog of beta-carbolines with anticancer activity, induces aberrant mitosis and delays mitotic exit. However, the cellular target is not known. In this study, we visualized the intracellular localization of Mana-Hox. Mana-Hox rapidly penetrated into cells (within 1 min) and concentrated on disorganized metaphase chromosomes after 13 hr of exposure. We demonstrated that Mana-Hox is a noncovalent DNA binder that can interact with DNA through intercalation and/or through minor groove binding. Furthermore, Mana-Hox also inhibits topoisomerase II relaxation activity in vitro, suggesting that Mana-Hox could perturb mitotic chromosome decatenation. Overall, Mana-Hox binding to DNA plays a critical role in the induction of aberrant mitosis and contributes to its anticancer activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology
  • Carbolines / chemistry*
  • Carbolines / metabolism
  • Carbolines / pharmacology
  • DNA / chemistry
  • DNA / drug effects*
  • DNA / metabolism*
  • DNA Topoisomerases, Type II / drug effects
  • HeLa Cells
  • Humans
  • Intercalating Agents / chemistry
  • Intercalating Agents / metabolism
  • Intercalating Agents / pharmacology
  • Mitosis / drug effects*
  • Models, Molecular
  • Molecular Structure
  • Topoisomerase II Inhibitors

Substances

  • Antineoplastic Agents
  • Carbolines
  • Intercalating Agents
  • Mana-Hox
  • Topoisomerase II Inhibitors
  • DNA
  • DNA Topoisomerases, Type II